129306-04-3

Basic information

• Product Name: 5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-
• Synonyms: 5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-;5-Benzyl-4,7-dioxo-5-azaspiro[2.4]heptane;5-benzyl-5-azaspiro[2.4]heptane-4,7-dione;5-(Phenylmethyl)-5-azaspiro[2.4]heptane-4,7-dione
• CAS NO: 129306-04-3
• Molecular Formula: C₁₃H₁₃NO₂
• Molecular Weight: 215.24782
• EINECS: -0
• Mol File: 129306-04-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-(129306-04-3)
• EPA Substance Registry System: 5-Azaspiro[2.4]heptane-4,7-dione, 5-(phenylMethyl)-(129306-04-3)

Safety Data

• Hazardous Substances Data: 129306-04-3(Hazardous Substances Data)

Usage

Uses

5-benzyl-5-azaspiro[2.4]heptane-4,7-dione is a useful research chemical.

Upstream product

• 32933-03-2 ethyl 1-acetylcyclopropanecarboxylate 
• 100-46-9 benzylamine 
• 129306-05-4 ethyl 1-(2-bromoacetyl)cyclopropanecarboxylate 
• 331443-52-8 N-benzyl-1-(2-bromoacetyl)cyclopropanecarboxamide 
• 147011-39-0 1-acetyl-N-[benzyl]cyclopropane-1-carboxamide 
• 882-36-0 N-benzyl-3-oxobutanamide 
• 207554-17-4 1-[2-(Benzyl-tert-butoxycarbonyl-amino)-acetyl]-cyclopropanecarboxylic acid ethyl ester 
• 207554-16-3 4-(Benzyl-tert-butoxycarbonyl-amino)-3-oxo-butyric acid ethyl ester 
• 76315-01-0 N-benzyl-N-(tert-butoxycarbonyl)glycine 
• 220969-69-7 1-(2-Benzylamino-acetyl)-cyclopropanecarboxylic acid ethyl ester 

Downstream Products

• 129306-06-5 4-oxo-5-benzyl-7-hydroxyimino-5-azaspiro[2,4]heptane 
• 144282-35-9 5-benzyl-7(S)-amino-5-azaspiro[2,4]heptane 
• 1432056-70-6 5-benzyl-7(S)-tert-butoxycarbonylamino-5-azaspiro[2,4]heptane 
• 944258-72-4 7-hydroxy-5-azaspiro[2.4]heptane 
• 152513-88-7 (7S)-5-aza-7-tert-butoxycarbonylaminospiro[2.4]heptan 
• 129306-13-4 5-phenylmethyl-N-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-7-amine 
• 129306-07-6 5-benzyl-5-azaspiro[2.4]heptane-7-amine 
• 129306-06-5 (7E)-5-benzyl-7-(hydroxyimino)-5-azaspiro[2.4]heptan-4-one 
• 129306-06-5 5-benzyl-7-(hydroxyimino)-4-oxo-5-azaspiro[2.4]heptane 
• 144282-41-7 (S)-7-amino-5-benzyl-5-azaspiro[2.4]heptan-4-one 
• 127199-45-5 (7S)-5-azaspiro[2.4]heptan-7-ylcarbamic acid tert-butyl ester 
• 180506-32-5 (R)-5-Benzyl-7-hydroxy-5-aza-spiro[2.4]heptan-4-one 
• 1152111-03-9 (7Z)-5-phenylmethyl-5-azaspiro[2.4]heptane-4,7-dione 7-O-methyloxime 

Relevant articles and documents

Having a spiro ring substituent of aryl morpholine compound, its preparation and use

The invention discloses arylmorpholine compounds with spiro substituents. The arylmorpholine compounds are compounds having the following general formula (I), wherein X is N or CH; R1 is hydrogen, hydroxyl, alkoxy, halogen, amino, amido, acylamino, sulfam

PEPTIDE DEFORMYLASE INHIBITORS

The present invention is directed to certain {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl}hydroxyformamide derivatives, compositions containing them, the use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity, and in the treatment of bacterial infections. Specifically, the invention is directed to compounds of formula (I), wherein R1, R2 and R3 are defined herein and to pharmaceutically acceptable salts thereof. The compounds of this invention are bacterial peptide deformylase inhibitors and can be useful in the treatment of bacterial infections.

Spiro compound

The present invention relates to spiro compounds of general formula I: STR1 wherein the substituents are herein below defined. The present invention relates to antibacterial spiro compounds which are of value as drugs for humans, veterinary drugs or drugs for use in fish culture or as preservatives, and to antibacterial compositions containing one or more of the same compounds as active ingredients.